Literature DB >> 7595027

Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cells.

R Hirschberg1, H Ding, C Wanner.   

Abstract

In vivo, proximal tubule cells are exposed to insulin-like growth factor I (IGF-I) that is present in serum or in proximal tubule fluid. For example, in the nephrotic syndrome, proximal tubule fluid contains IGF-I at biologically meaningful concentrations in association with IGF-binding protein-2 (IGFBP-2). IGF-I has also been shown to decrease the urinary excretion of phosphate (Pi) in normal subjects. We hypothesized that IGF-I can raise tubule cell Pi absorption directly through an apical as well as a basolateral tubule receptor mechanism, specifically, through IGF-I (type I) receptors as compared to IGF-II (type II) or insulin receptors. Studies were performed in cultured proximal tubule cells that express high-affinity IGF-I receptors. Stimulation of cells selectively at the apical or basolateral membrane with IGF-I (10(-9) to 10(-7) mol/L) increases Pi absorption by up to 80%, but a significant counterdirectional Pi flux in the apical-to-basolateral direction does not occur. The effect of IGF-I on Pi transport appears to be specific inasmuch as the transport of alanine is not affected by the peptide. IGFBP-2 does not inhibit this effect of IGF-I, but the IGF-I-induced increase in Pi transport is inhibited by a neutralizing anti-IGF-I receptor monoclonal antibody. Exposure of the cells to IGF-II (10(-7) mol/L) but not to insulin selectively at the apical membrane tends to increase Pi transport, and this IGF-II effect is also blocked by the anti-IGF-I receptor antibody.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595027

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

1.  Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

Authors:  R Hirschberg
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Hyperphosphatemia is prevalent among children with nephrotic syndrome and normal renal function.

Authors:  Sofia Feinstein; Rachel Becker-Cohen; Choni Rinat; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2006-08-08       Impact factor: 3.714

Review 3.  Insulin-like growth factor-I and insulin-like growth factor-binding proteins in the nephrotic syndrome.

Authors:  S M Feld; R Hirschberg
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 4.  Growth Hormone and IGF1 Actions in Kidney Development and Function.

Authors:  Evgenia Gurevich; Yael Segev; Daniel Landau
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

5.  Renal effects of growth hormone in health and in kidney disease.

Authors:  Dieter Haffner; Andrea Grund; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.